7SHU: IgE-Fc

IgE-Fc in complex with omalizumab variant C02. Determined by X-ray diffraction at 2.75 Å resolution. Released 15 Dec 2021.

Method
X-ray diffraction
Resolution
2.75 Å
Organism
Homo sapiens
Chains
6
Atoms
6,549
Mol. weight
106.92 kDa
Ligands
NAG, PO4
Released
15 Dec 2021

Explore 7SHU in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

7SHU contains 29 α-helices and 87 β-strands across 6 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 8 helices, 16 β-strands

ElementResiduesLengthSheet
α-helix342-3443
α-helix345-3462
α-helix347-3515
β-strand355-357319
β-strand373-376420
β-strand402-404319
α-helix407-4115
β-strand415-419520
β-strand430-434520
α-helix435-4373
β-strand441121
β-strand444-447422
β-strand463-469722
β-strand470121
β-strand475-480623
β-strand483-484223
α-helix487-4893
β-strand491-492222
α-helix493-4953
β-strand496-497222
β-strand503-508622
α-helix513-5186
β-strand522-527623
β-strand537-540423
Chain B: 13 helices, 20 β-strands
ElementResiduesLengthSheet
β-strand34017
α-helix341-3444
α-helix3451
α-helix346-3505
β-strand355-35847
α-helix369-3702
β-strand371-37668
α-helix380-3823
β-strand386-39057
β-strand398-40477
α-helix407-4115
β-strand416-42168
β-strand429-43358
α-helix435-4373
β-strand44119
α-helix442-4432
β-strand444-449610
α-helix450-4523
β-strand453111
β-strand456111
β-strand459-4691110
β-strand47019
β-strand475-480612
β-strand483-484212
α-helix485-4862
α-helix487-4893
β-strand490-492310
α-helix493-4953
β-strand496-497210
β-strand503-5121010
α-helix513-5186
β-strand522-527612
β-strand536-541612
Chain C: 1 helix, 12 β-strands
ElementResiduesLengthSheet
β-strand3-7513
β-strand11-12214
β-strand18-25813
β-strand34-40715
β-strand46-52715
β-strand58-60315
β-strand68-73613
β-strand78-83613
α-helix88-903
β-strand92-1021115
β-strand105-111715
β-strand115-117315
β-strand118-119214
Chain D: 3 helices, 13 β-strands
ElementResiduesLengthSheet
β-strand5-7316
β-strand10-13417
β-strand19-24616
β-strand30-31218
β-strand34-35218
β-strand37-42617
β-strand49-53517
β-strand57-58217
α-helix591
β-strand66-71616
β-strand74-79616
α-helix84-863
β-strand89-94617
α-helix1001
β-strand101-102217
β-strand106-110517
Chain E: 1 helix, 13 β-strands
ElementResiduesLengthSheet
β-strand3-751
β-strand11-1222
β-strand17-2591
β-strand34-4073
β-strand46-5383
β-strand58-6033
β-strand6511
β-strand68-7361
β-strand78-8471
α-helix88-903
β-strand92-102113
β-strand105-11173
β-strand115-11733
β-strand118-11922
Chain F: 3 helices, 13 β-strands
ElementResiduesLengthSheet
β-strand4-744
β-strand10-1235
β-strand19-2574
β-strand30-3126
β-strand34-3526
β-strand37-4265
β-strand49-5355
β-strand57-5825
α-helix591
β-strand66-7164
β-strand74-7964
α-helix84-863
β-strand89-9465
α-helix1001
β-strand101-10225
β-strand106-10945

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
omalizumab variant C02 VHC, Eprotein123Homo sapiens
omalizumab variant C02 VLD, Fprotein134Homo sapiens
Immunoglobulin heavy constant epsilonA, Bprotein220Homo sapiensP01854 (AlphaFold model)
Sequence of entity 1 (C, E), FASTA
>7SHU_1 omalizumab variant C02 VH (chains C, E)
SEVQLVESGGGLVQPDGSLRLSCAVSGYNITSGYSWNWIRQTPGKGLEWVASVTYDGSTN
YNPSVKGRITISRDGSKNTFYLQMNSLRAEDTAVYYCAKGNNYFGHWHFAVWGQGTLVTV
SSG
Sequence of entity 2 (D, F), FASTA
>7SHU_2 omalizumab variant C02 VL (chains D, F)
GSDIQLTQSPSSLSASVGDRVTITCRASKSVDSDGDSYMNWYQQKPGRAPKLLIYAASYL
ESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIKGGSENLY
FQGGSGHHHHHHHH
Sequence of entity 3 (A, B), FASTA
>7SHU_3 Immunoglobulin heavy constant epsilon (chains A, B)
GSCADSNPRGVSAYLSRPSPFDLFIRKSPTITCLVVDLAPSKGTVNLTWSRASGKPVNHS
TRKEEKQRNGTLTVTSTLPVGTRDWIEGETYQCRVTHPHLPRALMRSTTKTSGPRAAPEV
YAFATPEWPGSRDKRTLACLIQNFMPEDISVQWLHNEVQLPDARHSTTQPRKTKGSGFFV
FSRLEVTRAEWEQKDEFICRAVHEAASPSQTVQRAVSVNP

Ligands and cofactors

IDNameFormulaCopies
NAG2-acetamido-2-deoxy-beta-D-glucopyranoseC8 H15 N O61
PO4Phosphate ionO4 P1

Water and common crystallization additives (EDO) are not listed.

Primary citation

Directed evolution of and structural insights into antibody-mediated disruption of a stable receptor-ligand complex. Pennington, L.F., Gasser, P., Kleinboelting, S. et al. Nat Commun (2021) 12:7069-7069. DOI 10.1038/s41467-021-27397-z · PubMed

Other PDB entries of the same protein (UniProt P01854 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 7SHU directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.